Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06718920

Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment

The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are:

* Does the presence of ACE impact on quality of life of patients with multiple sclerosis? * Does it influence how the patients cope with the disease and with disease course-modifying therapies? During follow up visits, planned as part of their regular medical care, participants will answer survey questions on a tablet .

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, RM, 00168, Italy

Location status: Recruiting

Location contact

Alessandra Cicia, Neurologist

SUB_INVESTIGATOR

Assunta Bianco, Neurologist

SUB_INVESTIGATOR

Massimiliano Mirabella

CONTACT

[email protected]

0630155390

About this study

Multiple sclerosis is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system, typically affecting young adults. Its etiopathogenesis is multifactorial, with the interaction of genetic susceptibility and environmental risk factors. Among these, childhood trauma and other forms of adverse childhood experiences (ACE) such as divorce or parental loss have been called out as possible risk factors in the development of MS and disease relapse.

Adverse Childhood Experiences are a heterogeneous group of negative experiences occurred during childhood, that may have an unfavorable impact on the later course of life in terms of physical and mental health. These effects may be related to changes in the prefrontal, limbic, and hypothalamic-pituitary-adrenal areas and may cause repercussions on the immune system, as documented on experimental models of autoimmune encephalitis. In addition to that, a history of ACE has been associated with the development of poor coping strategies during adulthood . Since multiple sclerosis represents a chronic and progressive disease, the kind of coping strategies developed from childhood may affect how the patient perceives the disease and may affect his or her adherence to treatment.

To date, data on the prevalence of traumatic events during childhood in patients with Multiple Sclerosis are limited to a few studies, while the impact of such events on how the patient copes with the diagnosis of disease and acceptance of therapy. has not yet been explored.

This study represents a preliminary analysis of the impact of ACE in a cohort of multiple sclerosis patients and aims to evaluate how early negative life experiences may affect patients' coping strategies towards the disease and their compliance to treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age older than 18 years;
  • Diagnosis of relapsing-remitting multiple sclerosis according to McDonald criteria (2017 revisions) made between 2014 and 2024.
  • Signature of informed consent

Exclusion criteria

  • Presence of language barrier
  • Presence of conditions that prevent or limit understanding and proper completion of questionnaires

Treatment and study plan

Primary outcomes

  1. To assess the prevalence of ACE in a cohort of patients with relapsing-remitting multiple sclerosis

    Time frame: At enrollement

    The patients will answer to questionnaires provided on an electronic tablet during regular follow up neurological visits.

    The presence of adverse childhood experiences will be explored through the completion of a specific questionnaire:

    Childhood Trauma Questionnaire (CTQ): score 0-28 Higher scores mean higher probability to have experienced ACE

  2. To assess the prevalence of ACE in a cohort of patients with relapsing-remitting multiple sclerosis

    Time frame: At enrollement

    The patients will answer to questionnaires provided on an electronic tablet during regular follow up neurological visits.

    The presence of dysfunctional parenting during childhood will be explored through the completion of the Measure of Parental Style (MOPS) questionnaire (score 0-28): higher scores mean higher probability to have experienced dysfunctional parenting, leading to ACE

Secondary outcomes

  1. To correlate the impact of ACE on quality of life and general distress

    Time frame: 1 year

    Quality of life and general distress will be assessed through Brief Symptom Checklist (BSC): score 0-53, higher scores mean higher distress and worse quality of life

  2. To correlate the impact of ACE on how the patient perceives and copes with the disease

    Time frame: 1 year

    Quality of life and physician-patient relationship satisfaction will be assessed through patient reported outcomes

  3. To correlate the impact of ACE on treatment adherence

    Time frame: 1 year

    Treatment satisfaction and compliance will be assessed through patient reported otcomes

  4. To correlate the impact of ACE on disease treatment

    Time frame: 1 year

    To explore treatment satisfaction through the analysis of the number of treatment switches for poor tolerability

Study contacts

Contact information is provided by the study sponsor or research team.

Alessandra Cicia, Neurologist

CONTACT

[email protected]

0630155390

Massimiliano Mirabella, Neurology Associate Professor

CONTACT

[email protected]

0630155390

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

Single-center Observational Study to Characterize Adverse Childhood Experiences (ACE) in Patients With Multiple Sclerosis and Their Impact on Quality of Life, Disease Coping Strategies, and Adherence to Disease Course-modifying Therapies

Acronym: ACE-MS

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2024
Registry last updated
Feb 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.